Zaloguj się

Gotowe bibliografie tematyczne / Disease prevention / Artykuły w czasopismach

Artykuły w czasopismach na temat „Disease prevention”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Disease prevention.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 29 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Disease prevention”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Shakhnoza, Iskandarova, i Amilova Asalya. "PREVENTION OF CORONARY HEART DISEASE". American Journal of Medical Sciences and Pharmaceutical Research 04, nr 04 (1.04.2022): 19–21. http://dx.doi.org/10.37547/tajmspr/volume04issue04-05.

Pełny tekst źródła

Streszczenie:

Primary prevention, based on healthy lifestyle habits that prevent the emergence of risk factors, is the preferred method of reducing cardiovascular risk. Reducing the prevalence of obesity is the most urgent task, and it is pleiotropic in that it affects blood pressure, lipid profile, glucose metabolism, inflammation, progression of atherothrombotic disease. Physical activity also improves several risk factors, with the added potential to lower heart rate.

Style APA, Harvard, Vancouver, ISO itp.

2

&NA;. "DISEASE PREVENTION". American Journal of Nursing 99, nr 8 (sierpień 1999): 10. http://dx.doi.org/10.1097/00000446-199908000-00004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Pignone, Michael P., i Kirsten Bibbins-Domingo. "Disease Prevention". Medical Clinics of North America 101, nr 4 (lipiec 2017): i. http://dx.doi.org/10.1016/s0025-7125(17)30070-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Shubrook, Jay H. "Disease prevention". Osteopathic Family Physician 3, nr 5 (wrzesień 2011): 181. http://dx.doi.org/10.1016/j.osfp.2011.07.003.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Selby, JoeV. "DISEASE PREVENTION". Lancet 341, nr 8847 (marzec 1993): 728–29. http://dx.doi.org/10.1016/0140-6736(93)90493-z.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

SCHAPIRA, DAVID V. "Disease Prevention". Archives of Internal Medicine 149, nr 6 (1.06.1989): 1253. http://dx.doi.org/10.1001/archinte.1989.00390060007001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Zuo, Tongzhuo. "The Current Status of Occupational Disease Prevention". Learning & Education 9, nr 2 (10.11.2020): 6. http://dx.doi.org/10.18282/l-e.v9i2.1385.

Pełny tekst źródła

Streszczenie:

Occupational diseases are disorders of health resulting from conditions related to the workplace. There are 2.3 million deaths annually for reasons attributed to work globally, primarily to chemicals or dust. China has the largest working population in the world, with 776 million employed in 2018. According to the National Health Commission, about 12 million companies were found to have occupational-disease-inductive factors and at least 200 million people are exposed to occupational disease hazards. Preventing occupational diseases is a serious worldwide challenge. On the other hand, many developed countries already have rich experience in the prevention and treatment of various occupational diseases. They have set up various occupational disease prevention agencies and formulated strict occupational disease prevention systems. It is necessary for developing countries to learn from their advanced control measures.

Style APA, Harvard, Vancouver, ISO itp.

8

Mirzakarimova, Farida, Svetlana Kaleda, Natalia Polikarpova i Abdumurad Babadjanov. "NONALCOHOLIC FATTY LIVER DISEASE -SOME ASPECTS OF PREVENTION". UZBEK MEDICAL JOURNAL 2, nr 2 (28.02.2021): 15–24. http://dx.doi.org/10.26739/2181-0664-2021-2-3.

Pełny tekst źródła

Streszczenie:

Nowadays, NAFLD is considered one of the leading causes of chronic liver diseases globally.This is probably becausea patient with NAFLD usually had more severe diseases -diabetes mellitus type 2 (DM-2), metabolic syndrome, etc. On the one hand, after it was established that insulin resistance underlies these metabolic diseases and, on the other hand, that compensationfor these conditions does not eliminate NAFLD, and the presence of NAFLD worsens the course of the underlying disease, interest in its study increased significantly. The development of NAFLD is increasingly associated with the hypothesis of multifactorial parallel effects, or "multiple parallel hits" ("multiple parallel hits").

Style APA, Harvard, Vancouver, ISO itp.

9

Maeda, Kazuo. "Prevention of Choriocarcinoma after Postmolar Persistent Trophoblastic Disease". Women Health Care and Issues 2, nr 2 (10.12.2019): 01. http://dx.doi.org/10.31579/2642-9756/009.

Pełny tekst źródła

Streszczenie:

Also Chemotherapy was progresses in choriocarcinoma after Methotrexate, still its prevention with the treatment of persistent trophoblastic dusase is needed after molar treatment.The prevention was achieved with particular MTX treatment of persistenttrophoblastic disease.

Style APA, Harvard, Vancouver, ISO itp.

10

Aslam, Dr Imran, Yuldashev Soatboy Jiyanboyevich i Abdurakhmanova Zamira Ergashboevna. "Prevention & Treatment Of Cardiovascular Diseases". American Journal of Medical Sciences and Pharmaceutical Research 03, nr 06 (10.06.2021): 180–88. http://dx.doi.org/10.37547/tajmspr/volume03issue06-28.

Pełny tekst źródła

Streszczenie:

Cardiovascular disease is a significant problem that humans have always faced, affecting thousands of people's lives and health and taking the lives of many people. Many medical institutions and researchers have regarded it as a significant problem in overcoming the cardiovascular disease.1 Much attention has been paid, so the prevention and treatment level in this area has also been rapidly improved. However, cardiovascular disease still cannot be prevented or treated fundamentally, and it is still a significant danger to human health. All people still hope for breakthrough results in cardiovascular disease.2 This article analyzes the prevention and treatment of cardiovascular diseases, and has obtained a series of practical and reliable conclusions.

Style APA, Harvard, Vancouver, ISO itp.

11

Pipe, Andrew. "Cardiovascular disease prevention". Current Opinion in Cardiology 33, nr 5 (wrzesień 2018): 498–99. http://dx.doi.org/10.1097/hco.0000000000000551.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Van Camp, G. "Cardiovascular disease prevention". Acta Clinica Belgica 69, nr 6 (31.08.2014): 407–11. http://dx.doi.org/10.1179/2295333714y.0000000069.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Schargrodsky, Herman, María C. Escobar i Edgardo Escobar. "Cardiovascular Disease Prevention". Circulation 98, nr 20 (17.11.1998): 2103–4. http://dx.doi.org/10.1161/01.cir.98.20.2103.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Rendall, G. "Bee disease prevention". Veterinary Record 122, nr 13 (26.03.1988): 311–12. http://dx.doi.org/10.1136/vr.122.13.311.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Kapustin, Jane. "Chronic Disease Prevention". Journal for Nurse Practitioners 6, nr 1 (styczeń 2010): 6. http://dx.doi.org/10.1016/j.nurpra.2009.09.017.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Keevil, Jon G., James H. Stein i Patrick E. McBride. "Cardiovascular disease prevention". Primary Care: Clinics in Office Practice 29, nr 3 (wrzesień 2002): 667–96. http://dx.doi.org/10.1016/s0095-4543(02)00012-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Burns, Jackie. "Pneumococcal disease prevention". Primary Health Care 12, nr 8 (październik 2002): 24–26. http://dx.doi.org/10.7748/phc.12.8.24.s21.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Dietz, William H., Clifford E. Douglas i Ross C. Brownson. "Chronic Disease Prevention". JAMA 316, nr 16 (25.10.2016): 1645. http://dx.doi.org/10.1001/jama.2016.14370.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Pawar, Neha madhukar, i Archana Kulkarni. "CONCEPT OF VYADHIKSHAMATVA IN AYRVEDA". International Journal of Research -GRANTHAALAYAH 8, nr 8 (30.08.2020): 239–43. http://dx.doi.org/10.29121/granthaalayah.v8.i8.2020.1064.

Pełny tekst źródła

Streszczenie:

For prevention of diseases, Ayurveda had advocated the adherence to concepts like dina charya, ritu charya, sadvritta , Na vega dharan etc. these measures are useful in preventing the lifestyle related diseases but for preventing the Aupsargik rogas (communicable diseases), Janapada dhwansa rogas (epidemic diseases), Krumij Roga (Infectious diseases), Asatmyaj roga (allergic disorders), the concept of Vyadhikshamtva (Immunity) is propagated by the Ayurvedic science [1]. According to the concept of Ojas or Vyadhikshamatva or Bala (immunity), the body‟s resistance is of tremendous importance in the daily welfare of living beings not only for disease prevention but also for rapid recovery after disease affliction. [2] Ayurveda propounds that prevention is an equally important aspect of disease management as cure and thus, strengthening the immune system, is a natural way to help the body fight against the disease-causing pathogens. Acharyas promoted the use of Rasayana (Rejuvenation) to enhance ojas and vyadhikshamatva (immunity). This article is an effort to present Ayurvedic concepts of Vyadhishamatva.

Style APA, Harvard, Vancouver, ISO itp.

20

Turner, Chris. "Prevention, prevention". Faculty Dental Journal 10, nr 3 (lipiec 2019): 94–97. http://dx.doi.org/10.1308/rcsfdj.2019.94.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

O'g'li, Roxibjonov Adhamjon Raxmatjon. "PREVENTION OF DILATED CARDIOMYOPATHY DISEASE MEASURES TO TREAT IT". International Journal of Medical Sciences And Clinical Research 3, nr 12 (1.12.2023): 13–18. http://dx.doi.org/10.37547/ijmscr/volume03issue12-03.

Pełny tekst źródła

Streszczenie:

Dilated cardiomyopathy is myocardial dysfunction causing heart failure in which ventricular dilation and systolic dysfunction predominate. Symptoms include dyspnea, fatigue, and peripheral edema. Diagnosis is clinical and by elevated natriuretic peptides, chest x-ray, echocardiography, and MRI. Treatment is directed at the cause. If heart failure is progressive and severe, cardiac resynchronization therapy, implantable cardioverter-defibrillator, repair of moderate to severe valvular regurgitation, left ventricular assist device, or heart transplantation may be needed.

Style APA, Harvard, Vancouver, ISO itp.

22

Najmitdinovna, Kudratova Gulsara, i Ibragimova Yulduz Botyrovna. "PREVENTION OF BRONCHIAL ASTHMA IN CHILDREN AND TEENAGERS". American Journal Of Biomedical Science & Pharmaceutical Innovation 4, nr 3 (1.03.2024): 52–55. http://dx.doi.org/10.37547/ajbspi/volume04issue03-07.

Pełny tekst źródła

Streszczenie:

Bronchial asthma is considered a chronic disease and causes many health problems for the population. The disease is based on a genetic predisposition. Children whose parents have allergic diseases (bronchial asthma, allergic rhinitis, atopic dermatitis, eczema, Quincke's edema, etc.) have asthma in the first year of life the tendency to develop the disease is high. (25% if father or mother is sick with allergic diseases, 50% if allergic diseases are observed in both father and mother).

Style APA, Harvard, Vancouver, ISO itp.

23

Fugh-Berman, A., i S. Epstein. "Tamoxifen: disease prevention or disease substitution?" Lancet 340, nr 8828 (listopad 1992): 1143–45. http://dx.doi.org/10.1016/0140-6736(92)93161-f.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Berra, K., N. Houston Miller i J. M. Fair. "Cardiovascular Disease Prevention and Disease Management". Journal of Cardiopulmonary Rehabilitation 26, nr 4 (lipiec 2006): 197–206. http://dx.doi.org/10.1097/00008483-200607000-00001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Dmochowski, Tymon. "Green infrastructure as a disease prevention and rehabilitation tool". Przegląd Naukowy Inżynieria i Kształtowanie Środowiska 28, nr 4 (29.12.2019): 682–89. http://dx.doi.org/10.22630/pniks.2019.28.4.61.

Pełny tekst źródła

Streszczenie:

This article tackles with the problem of preventing diseases caused by physical inactivity. It offers a brief review of deadliest diseases and defi nes critical role of green public spaces in their prevention. Article presents patient treatment costs, in contrast to the costs of organizing green public spaces, suggesting substantial relief from economic burden sustained by national health fund by offering green public spaces designed specifi cally for disease prevention instead of conventional treatment.

Style APA, Harvard, Vancouver, ISO itp.

26

Vakrilova Becheva, Maria Stamova, Angelina Georgieva Kirkova-Bogdanova, Stefka Аchkova Ivanova, Petar Jordanov Atanasov, Mariya Sevdelinova Chaneva i Valentina Boyanova Petkova. "Prevention of cardiovascular diseases". Pharmacia 70, nr 4 (27.10.2023): 1243–47. http://dx.doi.org/10.3897/pharmacia.70.e114071.

Pełny tekst źródła

Streszczenie:

Cardiovascular diseases (CVD) are socially significant diseases due to high morbidity and loss of people of working age. In Bulgaria, they are the leading cause of mortality among the population and are a consequence of the effect of cardiovascular risk factors. The draft of the National Health Strategy (NHS) 2021–2030 reports on their wide distribution, as well as on the insufficient knowledge, skills and motivation for their prevention and control. The purpose of this review is to address the prevention of cardiovascular disease, which is a significant problem worldwide. Prevention goals for patients with established cardiovascular disease and those at high risk include smoking cessation, healthy eating, physical activity, and lowering body mass index. There are various methods that are part of health promotion to reduce CVD risks. These methods include motivational interviewing, non-pharmacological means, the use of certain medications for CVD prevention, as well as physical activity. Strategies for effective primary prevention refer to engaging the patient to change their lifestyle and identifying risk factors, while secondary prevention is aimed at activities to detect the disease early and to slow down its progression. It is necessary to create a strategy for timely preventive actions with a view to preventing the negative influence of risk factors and improving people‘s heart health.

Style APA, Harvard, Vancouver, ISO itp.

27

Chew, Emily Y. "Disease Management by Prevention". Disease Management and Health Outcomes 6, nr 5 (1999): 279–90. http://dx.doi.org/10.2165/00115677-199906050-00005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Traynor, Kate. "Disease prevention gains attention". American Journal of Health-System Pharmacy 66, nr 15 (1.08.2009): 1336–38. http://dx.doi.org/10.2146/news090063.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Lavie, Carl J., Ray W. Squires i Gerald T. Gau. "Prevention of cardiovascular disease". Postgraduate Medicine 81, nr 5 (kwiecień 1987): 52–72. http://dx.doi.org/10.1080/00325481.1987.11699780.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Tenenbaum, Ariel, Mohammed Morad i Joav Merrick. "Cardiovascular disease and prevention". International Journal of Adolescent Medicine and Health 26, nr 4 (1.11.2014): 457–58. http://dx.doi.org/10.1515/ijamh-2014-0004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Bauer, Michael, i Dominic Coppolo. "Agricultural Lung Disease: Prevention". Seminars in Respiratory and Critical Care Medicine 14, nr 01 (styczeń 1993): 83–89. http://dx.doi.org/10.1055/s-2007-1006311.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Coralli, Connie. "Disease Prevention/Health Promotion". Nurse Practitioner 15, nr 2 (luty 1990): 74. http://dx.doi.org/10.1097/00006205-199002000-00018.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Gardner, Pierce. "Prevention of Meningococcal Disease". New England Journal of Medicine 355, nr 14 (5.10.2006): 1466–73. http://dx.doi.org/10.1056/nejmcp063561.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Kornhuber, J. "Prevention of Alzheimer's Disease". Fortschritte der Neurologie · Psychiatrie 73, nr 6 (czerwiec 2005): 315–16. http://dx.doi.org/10.1055/s-2004-830309.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Filley, Christopher M. "Alzheimer disease prevention: Table". Neurology: Clinical Practice 5, nr 3 (29.12.2014): 193–200. http://dx.doi.org/10.1212/cpj.0000000000000108.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Zimmerman, Marcia. "Phytochemicals and Disease Prevention". Alternative and Complementary Therapies 1, nr 3 (kwiecień 1995): 154–57. http://dx.doi.org/10.1089/act.1995.1.154.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Szekely, C. A., J. C. S. Breitner i P. P. Zandi. "Prevention of Alzheimer's disease". International Review of Psychiatry 19, nr 6 (styczeń 2007): 693–706. http://dx.doi.org/10.1080/09540260701797944.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Thal, Leon J. "Prevention of Alzheimer Disease". Alzheimer Disease & Associated Disorders 20, Supplement 2 (lipiec 2006): S97—S99. http://dx.doi.org/10.1097/00002093-200607001-00015.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Bloomgarden, Z. T. "Prevention of Cardiovascular Disease". Diabetes Care 30, nr 2 (26.01.2007): 423–31. http://dx.doi.org/10.2337/dc07-zb02.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

&NA;. "Prevention of heart disease". Inpharma Weekly &NA;, nr 833 (kwiecień 1992): 3. http://dx.doi.org/10.2165/00128413-199208330-00004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Paixao, Andre R. M., Colby R. Ayers, Jarett D. Berry, James A. de Lemos i Amit Khera. "Atherosclerotic Cardiovascular Disease Prevention". Circulation: Cardiovascular Quality and Outcomes 7, nr 5 (wrzesień 2014): 778–79. http://dx.doi.org/10.1161/circoutcomes.114.001139.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Holmes, Julia S., Irma E. Arispe i Ernest Moy. "Heart Disease and Prevention". Medical Care 43, Supplement (marzec 2005): I—33—I—41. http://dx.doi.org/10.1097/00005650-200503001-00006.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Porena, M., P. Guiggi i C. Micheli. "Prevention of Stone Disease". Urologia Internationalis 79, nr 1 (2007): 37–46. http://dx.doi.org/10.1159/000104440.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Couch, Patricia, i Gary E. Johnson. "Prevention of Lyme disease". American Journal of Health-System Pharmacy 49, nr 5 (1.05.1992): 1164–73. http://dx.doi.org/10.1093/ajhp/49.5.1164.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

King, Kathryn M., i Heather M. Arthur. "Coronary Heart Disease Prevention". Journal of Cardiovascular Nursing 18, nr 4 (wrzesień 2003): 274–81. http://dx.doi.org/10.1097/00005082-200309000-00006.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Hill, Martha N., i George A. Mensah. "Global Cardiovascular Disease Prevention". Journal of Cardiovascular Nursing 26, Supplement (lipiec 2011): S4. http://dx.doi.org/10.1097/jcn.0b013e318213efe4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Berra, Kathy, Barbara Fletcher, Laura L. Hayman i Nancy Houston Miller. "Global Cardiovascular Disease Prevention". Journal of Cardiovascular Nursing 28, nr 6 (2013): 505–13. http://dx.doi.org/10.1097/jcn.0b013e31826b6822.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Schafer, Tara E., i Steven M. Adair. "PREVENTION OF DENTAL DISEASE". Pediatric Clinics of North America 47, nr 5 (październik 2000): 1021–42. http://dx.doi.org/10.1016/s0031-3955(05)70256-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Rose, Geoffrey, M. P. H. Doublet Stewart, ChristopherA Birt, PeterR Croft i PatrickF James. "CORONARY HEART DISEASE PREVENTION". Lancet 332, nr 8619 (listopad 1988): 1081–82. http://dx.doi.org/10.1016/s0140-6736(88)90102-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Mccormick, JamesS, Petr Skrabanek, J. A. Lee i R. C. Cottrell. "CORONARY HEART DISEASE PREVENTION". Lancet 332, nr 8621 (listopad 1988): 1189–90. http://dx.doi.org/10.1016/s0140-6736(88)90252-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!